Table 1.
COVID-19 comorbidity | S-Polysaccharides | Origin | Proposed mechanisms of action | Current state | References |
---|---|---|---|---|---|
Hypertension | Fucoidans | Brown seaweeds | Mimicking natural ligands of protein receptors | Research | [4] |
Cardiovascular disease | Sulfated fucans and galactans | Brown seaweeds and sea urchin | Inhibition of factor Xa and thrombin generations by the tenase and prothrombinase systems. | Research | [5] |
Type 2 diabetes/obesity | Sulfated rhamnose, fucoidan | Enteromorpha prolifera | Sulfated rhamnose-Cr (III) ligands can significantly improve the bioactivity of chromium and increase its ability to control diabetes. | Proposed as nutraceutical | [6,7] |